Athersys still excited about Pfizer stem cell collaboration
Updated 2:49 p.m., May 7, 2010. Biopharmaceutical company Athersys Inc. (NASDAQ: ATHX) is excited to be working with Pfizer Regenerative Medicine on a stem cell treatment for inflammatory bowel disease. But you’ll have to attend the Cleveland company’s 2010 investor and research & development day in New York City on May 14 to find out why. Ruth McKernan, [...]
[Read the full article here]Related News:
Experts laud potential of Athersys stem cell therapy MultiStem
Athersys Soars On Stem Cell Development Deal with Pfizer
Pfizer Regenerative Medicine to work wth Athersys on stem cell therapies